2Castranova V. Role of nitric oxide in the progression of pneumoconiosis[J].Bioehemistry (Mose), 2004, 69(1) :32- 37.
3Zeidler P, Hubbs A, BatteUi L, et al. Role of inducible nitric oxide synthase-derived nitric oxide in silica-induced pulmonary inflammation and fibrosis[J]. Toxieol Environ Health A, 2004, 67 (13) :1001-1026.
4Altin R, Armutcu F, Kart L, et al. Antioxidant response at early stages and low grades of simple coal worker's pneumoconiosis diagnosed by high resolution computed tomography [ J]. Int J Hyg Environ Health, 2004, 207 (5) :455 - 462.
5Chiu PY, Ko KM. Time-dependent enhancement in mitochondrial glutathione status and ATP generation capacity by schisandrin B treatment decreases the susceptibility of rat hearts to ischemiareperfusion injury [ J ]. BioFactors, 2003,19 : 43 - 51.
6Chiu PY, Leung HY, Poon MK, et al. Chronic schisandrin B treatment improves mitochondrial antioxidant status and tissue heat shock protein production in various tissues of young adult and middleaged rats[J]. Biagerontology, 2006,7(4) :199 - 210.
7Pan SY, Dong H, Zhao XY, et al. Schisandrin B from Schisandra chinensis reduces hepatic lipid contents in hypercholesterolaemic mice [J]. Pharm Pharmacol, 2008, 60(3): 399- 403.
8Lyer SN, Rujeyalakshmi GGu, Girl SN. Effect of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis [J]. J Pharmaeol Exp Ther, 1999,289 (1):211-218.
9Raymond F, Hamilton Jr. a, Sheetal A, et al. Silica binding and toxicity in alveolar macrophages[J]. Free Radic Biol Med,2008,44 (7) : 1246 - 1258.
